Sonendo, Inc. to Release Third Quarter 2024 Financial Results and Postpone Conference Call on November 12, 2024
Sonendo (OTCQX: SONX), a dental technology company known for the GentleWave® System, has announced the postponement of its third quarter 2024 earnings conference call, which was originally scheduled for November 12th, 2024. While the company will proceed with filing its audited financial results on the planned date, management has delayed the accompanying conference call indefinitely. Commentary on post-quarter events will be provided at a later date.
Sonendo (OTCQX: SONX), un'azienda di tecnologia dentale nota per il sistema GentleWave®, ha annunciato il rinvio della sua conferenza sugli utili del terzo trimestre 2024, originariamente programmata per il 12 novembre 2024. Sebbene l'azienda procederà con la presentazione dei risultati finanziari auditati nella data prevista, la direzione ha posticipato indefinitamente la conferenza telefonica correlata. I commenti sugli eventi successivi al trimestre saranno forniti in una data successiva.
Sonendo (OTCQX: SONX), una empresa de tecnología dental conocida por el sistema GentleWave®, ha anunciado el aplazamiento de su conferencia de ganancias del tercer trimestre de 2024, que estaba programada originalmente para el 12 de noviembre de 2024. Aunque la empresa procederá a presentar sus resultados financieros auditados en la fecha planificada, la dirección ha retrasado indefinidamente la conferencia telefónica que la acompaña. Se proporcionará un comentario sobre los eventos posteriores al trimestre en una fecha posterior.
Sonendo (OTCQX: SONX), GentleWave® 시스템으로 알려진 치과 기술 회사가 2024년 3분기 실적 컨퍼런스 콜을 원래 예정된 2024년 11월 12일에서 연기한다고 발표했습니다. 회사는 예정된 날짜에 감사된 재무 결과를 제출하겠지만 경영진은 관련 컨퍼런스 콜을 무기한 연기했습니다. 분기 후 사건에 대한 논평은 나중에 제공될 것입니다.
Sonendo (OTCQX: SONX), une entreprise de technologie dentaire connue pour son système GentleWave®, a annoncé le report de sa conférence téléphonique sur les résultats du troisième trimestre 2024, qui était initialement prévue pour le 12 novembre 2024. Bien que l'entreprise procède à la soumission de ses résultats financiers audités à la date prévue, la direction a reporté indéfiniment la conférence téléphonique qui l'accompagne. Des commentaires sur les événements post-trimestriels seront fournis à une date ultérieure.
Sonendo (OTCQX: SONX), ein Dentaltechnologieunternehmen, das für das GentleWave®-System bekannt ist, hat die Verschiebung seines Gewinnaufrufs für das dritte Quartal 2024 bekannt gegeben, der ursprünglich für den 12. November 2024 angesetzt war. Während das Unternehmen die Einreichung seiner geprüften Finanzberichte am geplanten Datum durchführen wird, hat das Management den begleitenden Gewinnaufruf auf unbestimmte Zeit verschoben. Kommentare zu den Ereignissen nach dem Quartal werden zu einem späteren Zeitpunkt bereitgestellt.
- None.
- Unexpected postponement of earnings call may signal potential concerns
- Lack of immediate management commentary on Q3 results could create market uncertainty
The Company still intends to file its audited financial results on November 12th, 2024, but has postponed, until further notice, the accompanying conference call. Management will provide commentary on events subsequent to the end of the quarter ending September 30th, 2024, at a later date.
About Sonendo
Sonendo is a commercial-stage medical technology Company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. Sonendo develops and manufactures the GentleWave® System, an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. The clinical benefits of the GentleWave System when compared to conventional methods of root canal therapy include improved clinical outcomes, such as superior cleaning that is independent of root canal complexity and tooth anatomy, high and rapid rates of healing and minimal to no post-operative pain. In addition, the GentleWave System can improve the workflow and economics of dental practices.
For more information about Sonendo and the GentleWave System, please visit www.sonendo.com. To find a GentleWave doctor in your area, please visit www.gentlewave.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241111083660/en/
Investor Contact
Gilmartin Group
Greg Chodaczek
ir@sonendo.com
Source: Sonendo
FAQ
When will Sonendo (SONX) release its Q3 2024 financial results?
Why did Sonendo (SONX) postpone its Q3 2024 earnings conference call?
Will Sonendo (SONX) provide commentary on post-Q3 2024 events?
